Clover Health Investments Corp (NASDAQ:CLOV) has a beta value of 1.99 and has seen 0.49 million shares traded in the recent trading session. The company, currently valued at $1.81B, closed the recent trade at $3.55 per share which meant it lost -$0.04 on the day or -1.25% during that session. The CLOV stock price is -37.18% off its 52-week high price of $4.87 and 82.82% above the 52-week low of $0.61. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.32 million shares traded. The 3-month trading volume is 6.06 million shares.
The consensus among analysts is that Clover Health Investments Corp (CLOV) is Hold stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 1 have rated it as a Hold, with 0 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.07.
Clover Health Investments Corp (NASDAQ:CLOV) trade information
Sporting -1.25% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the CLOV stock price touched $3.55 or saw a rise of 7.55%. Year-to-date, Clover Health Investments Corp shares have moved 12.54%, while the 5-day performance has seen it change -4.96%. Over the past 30 days, the shares of Clover Health Investments Corp (NASDAQ:CLOV) have changed -4.70%. Short interest in the company has seen 13.14 million shares shorted with days to cover at 1.99.
Wall Street analysts have a consensus price target for the stock at $6, which means that the shares’ value could jump 40.83% from the levels at last check today. The projected low price target is $6.0 while the price target rests at a high of $6.0. In that case, then, we find that the latest price level in today’s session is -69.01% off the targeted high while a plunge would see the stock gain -69.01% from the levels at last check today.
Clover Health Investments Corp (CLOV) estimates and forecasts
The company’s shares have gained 25.71% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 36.00%.
4 analysts offering their estimates for the company have set an average revenue estimate of 466.93M for the current quarter. 4 have an estimated revenue figure of 474.88M for the next ending quarter. Year-ago sales stood 346.92M and 356.26M respectively for this quarter and the next, and analysts expect sales will grow by 34.59% for the current quarter and 36.00% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -237.67% over the past 5 years. Earnings growth for 2025 is a modest -80.25% while over the next 5 years, the company’s earnings are expected to increase by 40.98%.
CLOV Dividends
Clover Health Investments Corp is expected to release its next earnings report on 2025-Feb-26 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Clover Health Investments Corp (NASDAQ:CLOV)’s Major holders
Insiders own 5.09% of the company shares, while shares held by institutions stand at 22.40% with a share float percentage of 23.60%. Investors are also buoyed by the number of investors in a company, with Clover Health Investments Corp having a total of 212.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 17.35 million shares worth more than $21.33 million. As of 2024-06-30, VANGUARD GROUP INC held 3.5662% of shares outstanding.
The other major institutional holder is RENAISSANCE TECHNOLOGIES LLC, with the holding of over 11.27 million shares as of 2024-06-30. The firm’s total holdings are worth over $13.86 million and represent 2.3123% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund. As of Dec 31, 2024, the former fund manager holds about 2.62% shares in the company for having 10.96 shares of worth $39.07 million while later fund manager owns 6.22 shares of worth $22.16 million as of Dec 31, 2024, which makes it owner of about 1.49% of company’s outstanding stock.
